Jessica Tassan
Stock Analyst at Piper Sandler
(1.87)
# 3,263
Out of 5,032 analysts
83
Total ratings
34.92%
Success rate
-6.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $22.29 | +52.53% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $7.53 | +139.04% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $3.05 | +31.15% | 12 | Aug 27, 2025 | |
| PINC Premier | Maintains: Neutral | $24 → $28 | $28.00 | - | 8 | Aug 25, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $55.26 | +55.63% | 3 | Aug 15, 2025 | |
| OSCR Oscar Health | Maintains: Neutral | $14 → $13 | $19.39 | -32.96% | 6 | Aug 14, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $67.57 | +2.12% | 4 | Aug 11, 2025 | |
| HUM Humana | Maintains: Neutral | $288 → $272 | $275.01 | -1.09% | 4 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $353 → $317 | $356.60 | -11.10% | 8 | Jul 30, 2025 | |
| HNGE Hinge Health | Initiates: Overweight | $41 | $49.28 | -16.80% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $10 → $8 | $5.45 | +46.79% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $299.27 | +24.97% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $72 → $74 | $82.52 | -10.32% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $17.12 | +22.66% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $8.53 | +40.68% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $29.90 | +134.11% | 4 | Aug 2, 2023 |
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $22.29
Upside: +52.53%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $7.53
Upside: +139.04%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $3.05
Upside: +31.15%
Premier
Aug 25, 2025
Maintains: Neutral
Price Target: $24 → $28
Current: $28.00
Upside: -
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $55.26
Upside: +55.63%
Oscar Health
Aug 14, 2025
Maintains: Neutral
Price Target: $14 → $13
Current: $19.39
Upside: -32.96%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $67.57
Upside: +2.12%
Humana
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $275.01
Upside: -1.09%
UnitedHealth Group
Jul 30, 2025
Maintains: Overweight
Price Target: $353 → $317
Current: $356.60
Upside: -11.10%
Hinge Health
Jun 16, 2025
Initiates: Overweight
Price Target: $41
Current: $49.28
Upside: -16.80%
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $5.45
Upside: +46.79%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $299.27
Upside: +24.97%
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $82.52
Upside: -10.32%
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $17.12
Upside: +22.66%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $8.53
Upside: +40.68%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $29.90
Upside: +134.11%